Group One Trading
CUE icon

Group One Trading’s Cue Biopharma CUE Stock Holding History

Group One Trading’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$947 Buy
+30
New +$678 ﹤0.01% 7193
2025
Q2 		– Sell
-452
Closed -$12.4K – 8028
2025
Q1 		$12.4K Buy
+452
New +$16.8K ﹤0.01% 6116
2023
Q4 		– Sell
-176
Closed -$12.6K – 7517
2023
Q3 		$12.1K Buy
+176
New +$17.2K ﹤0.01% 6235
2023
Q2 		– Sell
-53
Closed -$6.23K – 7726
2023
Q1 		$5.63K Buy
+53
New +$5.05K ﹤0.01% 6229
2022
Q3 		– Sell
-486
Closed -$41.8K – 7634
2022
Q2 		$36K Buy
486
+327
+206% +$38.3K ﹤0.01% 5832
2022
Q1 		$23K Buy
+159
New +$33.7K ﹤0.01% 6663
2021
Q4 		– Sell
-10
Closed -$3.87K – 8302
2021
Q3 		$5K Sell
10
-47
-82% -$16.4K ﹤0.01% 7725
2021
Q2 		$20K Buy
+57
New +$22.1K ﹤0.01% 7178

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Group One Trading's CUE Position: Q2 2026 in Review

Group One Trading opened a new position in Cue Biopharma (CUE) in Q2 2026: 30 shares worth $947. The stake represents ﹤0.01% of the portfolio and ranks #7193 among its holdings. This is a return to the name: Group One Trading previously reported a position in CUE as recently as Q1 2025.

Group One Trading first reported a position in CUE in Q2 2021 and has held it in 8 quarters since. The position peaked at $36K in Q2 2022. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Group One Trading held 30 shares of Cue Biopharma worth $947 as of Q2 2026.
  • Cue Biopharma was a new Group One Trading position in Q2 2026.
  • Cue Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7193 holding.
  • Group One Trading first reported a position in Cue Biopharma in Q2 2021 and has held it in 8 quarters since.
  • Group One Trading's Cue Biopharma position peaked at $36K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.